Document is current

Article History

Received: 3 June 2024

Accepted: 16 January 2025

First Online: 14 February 2025

Competing interests

: I.D. has received speaker honoraria and travel grants from Abbott Medical, Biosense Webster, Boston Scientific, Daiichi Sankyo, Bristol Myer Squibbs, and Volta Medical. J.-P.A. has served as a consultant for Abbott Medical, Medtronic, and Volta Medical. S.B. has received speaker and consultancy honoraria from Biosense Webster, Medtronic, Biotronik, Impulse Dynamics, Pfizer, and Volta Medical. E.G. has served as a consultant for Abbott Medical. S.E.M. has received honoraria from Volta Medical. J.H. has served as a consultant for Abbott Medical and has received honoraria for participation in advisory board from Medtronic. S.O. has served as a consultant for Volta Medical, Biosense Webster, Boston Scientific, GE Healthcare, AtriCure, and PaceMate, has received research grant from Boston Scientific, and is a shareholder of HRCRS/3PH and PaceMate. F.B. has served as a consultant for Biosense Webster and Volta Medical. T.D.P. has served as a consultant for Boston Scientific and has received research grants from Biosense Webster. C.D.C. has received speaker honoraria and travel grants from Biosense Webster, Abbott Medical, and Boston Scientific. S.G. has received honoraria for participation in advisory board and equity from Volta Medical. A.V. has received research grants from Biosense Webster, Medtronic, and Bayer, and has served in advisory boards at Biosense Webster, Medtronic, Volta Medical, Medlumics, Abbott Medical, and Adagio. J.D.H. has served as a consultant for Medtronic, Abbott Medical, and Volta Medical. T.M.D. is a co-founder, shareholder, and CEO of Volta Medical. P.M., A.A., and D.G. are employees of Volta Medical. The other authors declare no competing interests.